NPS PHARMACEUTICALS INC: accounts_payable
| Value | {"amount": 10919000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-12-31) |
| Status | current |
| Entity | NPS PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:56:45.347475+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2ec2ece1-718a-42d4-b246-36afd060e9be
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001136261-14-000082 · Open the official SEC filing →Retrieved: 2026-08-19T08:56:45.347475+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000890465/accounts-payable/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2ec2ece1-718a-42d4-b246-36afd060e9be
History
- no predecessors — first report